Mark Griffiths

10.9k total citations · 2 hit papers
154 papers, 7.1k citations indexed

About

Mark Griffiths is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, Mark Griffiths has authored 154 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Pulmonary and Respiratory Medicine, 32 papers in Physiology and 22 papers in Surgery. Recurrent topics in Mark Griffiths's work include Respiratory Support and Mechanisms (34 papers), Neonatal Respiratory Health Research (21 papers) and Intensive Care Unit Cognitive Disorders (15 papers). Mark Griffiths is often cited by papers focused on Respiratory Support and Mechanisms (34 papers), Neonatal Respiratory Health Research (21 papers) and Intensive Care Unit Cognitive Disorders (15 papers). Mark Griffiths collaborates with scholars based in United Kingdom, United States and Bulgaria. Mark Griffiths's co-authors include Timothy W. Evans, Dean Sheppard, Xiaozhu Huang, Jean‐François Pittet, Naftali Kaminski, Michael A. Matthay, Stephen Dalton, Jianfeng Wu, John S. Munger and Daniel B. Rifkin and has published in prestigious journals such as New England Journal of Medicine, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Mark Griffiths

149 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Mechanism for Regulating Pulmonary Inflammation and Fibrosis: The Integrin αvβ6 Binds and Activates Latent TGF β1

1999 1.6k citations John S. Munger, Xiaozhu Huang et al. Cell profile →
Guidelines on the management of acute respiratory distress syndrome

2019 311 citations Mark Griffiths, Daniel F. McAuley et al. BMJ Open Respiratory Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Griffiths United Kingdom	36	2.9k	1.9k	1.0k	842	783	154	7.1k
Jahar Bhattacharya United States	45	3.1k 1.1×	2.8k 1.4×	866 0.9×	1.2k 1.4×	1.2k 1.5×	122	7.6k
Kurt H. Albertine United States	48	4.0k 1.4×	1.6k 0.8×	792 0.8×	2.0k 2.3×	1.4k 1.8×	199	8.0k
Rachel C. Chambers United Kingdom	49	4.1k 1.4×	1.7k 0.9×	695 0.7×	744 0.9×	975 1.2×	130	8.2k
Charles W. Frevert United States	44	2.3k 0.8×	1.7k 0.9×	592 0.6×	538 0.6×	2.4k 3.0×	120	6.5k
Gísli Jenkins United Kingdom	42	3.7k 1.3×	1.7k 0.9×	844 0.8×	429 0.5×	614 0.8×	149	6.9k
Robin J. McAnulty United Kingdom	52	3.7k 1.3×	1.9k 1.0×	901 0.9×	793 0.9×	765 1.0×	121	7.4k
Geoffrey J. Laurent United Kingdom	61	4.8k 1.7×	2.6k 1.3×	1.1k 1.1×	1.5k 1.8×	954 1.2×	163	11.0k
Arnold E. Postlethwaite United States	52	1.7k 0.6×	2.7k 1.4×	622 0.6×	1.1k 1.3×	2.1k 2.7×	166	11.0k
Hal K. Hawkins United States	53	1.6k 0.6×	2.0k 1.0×	1.5k 1.5×	1.4k 1.6×	1.4k 1.7×	223	9.9k
Thomas Geiser Switzerland	41	2.3k 0.8×	1.2k 0.6×	740 0.7×	593 0.7×	1.3k 1.7×	195	6.4k

Countries citing papers authored by Mark Griffiths

Since Specialization

Citations

This map shows the geographic impact of Mark Griffiths's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Griffiths with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Griffiths more than expected).

Fields of papers citing papers by Mark Griffiths

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Griffiths. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Griffiths. The network helps show where Mark Griffiths may publish in the future.

Co-authorship network of co-authors of Mark Griffiths

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Griffiths. A scholar is included among the top collaborators of Mark Griffiths based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Griffiths. Mark Griffiths is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wright, Matthew, Konstantinos N. Bourdakos, Sumeet Mahajan, et al.. (2025). Knock-out mouse models and single particle ICP-MS reveal that SP-D and SP-A deficiency reduces agglomeration of inhaled gold nanoparticles in vivo without significant changes to overall lung clearance. Nanotoxicology. 19(1). 119–140. 1 indexed citations

Griffiths, Mark, et al.. (2020). Human reliability analysis of bronchoscope-assisted percutaneous dilatational tracheostomy: implications for simulation-based education. SHILAP Revista de lepidopterología. 5(1). 30–30. 4 indexed citations

Griffiths, Mark, Daniel F. McAuley, Gavin D. Perkins, et al.. (2019). Guidelines on the management of acute respiratory distress syndrome. BMJ Open Respiratory Research. 6(1). e000420–e000420. 311 indexed citations breakdown →

Ng-Blichfeldt, John-Poul, Reinoud Gosens, Charlotte Dean, Mark Griffiths, & Matthew Hind. (2019). Regenerative pharmacology for COPD: breathing new life into old lungs. Thorax. 74(9). 890–897. 27 indexed citations

Paúl, Richard, Amy Lewis, Benjamin Garfield, et al.. (2017). MicroRNA-542 Promotes Mitochondrial Dysfunction and SMAD Activity and Is Elevated in Intensive Care Unit–acquired Weakness. American Journal of Respiratory and Critical Care Medicine. 196(11). 1422–1433. 62 indexed citations

Polkey, Michael I., Mark Griffiths, & Paul R. Kemp. (2016). Muscle Regeneration after Critical Illness: Are Satellite Cells the Answer?. American Journal of Respiratory and Critical Care Medicine. 194(7). 780–782. 7 indexed citations

Kendall, Michaela, Rose‐Marie Mackay, Harry J. Whitwell, et al.. (2015). Surfactant protein A (SP-A) inhibits agglomeration and macrophage uptake of toxic amine modified nanoparticles. Nanotoxicology. 9(8). 952–962. 29 indexed citations

Price, Laura, Gaetano Caramori, Frédéric Perros, et al.. (2013). Nuclear Factor κ-B Is Activated in the Pulmonary Vessels of Patients with End-Stage Idiopathic Pulmonary Arterial Hypertension. PLoS ONE. 8(10). e75415–e75415. 79 indexed citations

Bloch, Susannah, Michael I. Polkey, Mark Griffiths, & Paul R. Kemp. (2011). Molecular mechanisms of intensive care unit-acquired weakness. European Respiratory Journal. 39(4). 1000–1011. 60 indexed citations

10.

Charron, Catherine E., Pai-Chien Chou, Vaibhav Kumar, et al.. (2009). Hypoxia-inducible Factor 1α Induces Corticosteroid-insensitive Inflammation via Reduction of Histone Deacetylase-2 Transcription. Journal of Biological Chemistry. 284(52). 36047–36054. 44 indexed citations

11.

Cordingley, Jeremy, et al.. (2009). Extracorporeal carbon dioxide removal to "protect" the lung. Thorax. 64(8). 726–727. 3 indexed citations

12.

Moloney, E, Sharon Mumby, Julius Cranshaw, et al.. (2003). Exhaled Breath Condensate Detects Markers of Pulmonary Inflammation after Cardiothoracic Surgery. American Journal of Respiratory and Critical Care Medicine. 169(1). 64–69. 57 indexed citations

13.

Pinhu, Liao, et al.. (2003). Ventilator-associated lung injury. The Lancet. 361(9354). 332–340. 283 indexed citations

14.

Munger, John S., Xiaozhu Huang, Hisaaki Kawakatsu, et al.. (1999). A Mechanism for Regulating Pulmonary Inflammation and Fibrosis: The Integrin αvβ6 Binds and Activates Latent TGF β1. Cell. 96(3). 319–328. 1641 indexed citations breakdown →

15.

Griffiths, Mark, Nick Curzen, Jane A. Mitchell, & Timothy W. Evans. (1997). In Vivo Treatment with Endotoxin Increases Rat Pulmonary Vascular Contractility Despite NOS Induction. American Journal of Respiratory and Critical Care Medicine. 156(2). 654–658. 22 indexed citations

16.

Griffiths, Mark, et al.. (1997). Human protamines and male infertility. Journal of Assisted Reproduction and Genetics. 14(5). 282–290. 28 indexed citations

17.

Griffiths, Mark, Mark Messent, Nick Curzen, & Timothy W. Evans. (1995). Aminoguanidine Selectively Decreases Cyclic GMP Levels Produced by Inducible Nitric Oxide Synthase. American Journal of Respiratory and Critical Care Medicine. 152(5). 1599–1604. 25 indexed citations

18.

Barrett, A.W., Mark Griffiths, & C Scully. (1993). The de Lange syndrome in association with a bleeding tendency: Oral surgical implications. International Journal of Oral and Maxillofacial Surgery. 22(3). 171–172. 1 indexed citations

19.

Mackenzie, W. E., et al.. (1988). Direct and short‐term culture preparation of chorionic villi. Is any one method best?. Prenatal Diagnosis. 8(7). 501–509. 1 indexed citations

20.

Griffiths, Mark & T.A. Thomas. (1985). A comparison of the analgesic effects of meptazinol and pentazocine following removal of impacted third molars. BDJ. 158(1). 19–21. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact